Arvinas, Inc. (ARVN) vs Electra Therapeutics Inc. (ETRA)

Arvinas, Inc. ARVN 7.56 −3.82%
Electra Therapeutics Inc. ETRA 7.32 −9.63%

Arvinas, Inc. and Electra Therapeutics Inc. are both Biotechnology companies. Arvinas, Inc. and Electra Therapeutics Inc. are of similar size ($513.9M and $508.4M).

Metric	ARVN	ETRA	Biotechnology median
P/E	39.48	—	10.71
P/S	1.55	—	9.84
P/B	0.87	—	2.15
Price to free cash flow	n/m	—	25.78
EV/EBITDA	4.27	—	0.65
EV/Sales	(0.24)	—	9.47
Earnings yield	2.53%	—	(34.53%)
Free cash flow yield	(42.62%)	—	(24.00%)

Metric	ARVN	ETRA	Biotechnology median
Gross margin	97.16%	—	69.20%
Operating margin	(5.72%)	—	0.00%
Net margin	2.94%	—	0.00%
Free cash flow margin	(65.93%)	—	0.00%
Return on equity	1.59%	—	(53.10%)
Return on assets	1.17%	—	(46.06%)
Return on invested capital	0.00%	—	0.00%

Metric	ARVN	ETRA	Biotechnology median
Revenue growth (TTM)	(15.05%)	—	5.26%
EPS growth (last fiscal year)	58.84%	—	29.88%
Revenue growth, 5-year CAGR	58.93%	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	ARVN	ETRA	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	7.91	—	4.98
Net debt to EBITDA	5.62	—	1.01

Metric	ARVN	ETRA	Biotechnology median
Dividend yield	—	—	0.39%
Payout ratio	—	—	—

Metric	ARVN	ETRA	Biotechnology median
Market cap	513.94m	508.41m	171.46m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack